Institute of Plant Biology, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.
Doctoral School of Biology, University of Szeged, Szeged, Hungary.
PLoS One. 2019 Nov 26;14(11):e0225375. doi: 10.1371/journal.pone.0225375. eCollection 2019.
We developed a simple method to apply CRISPR interference by modifying an existing plasmid pCRISPathBrick containing the native S. pyogenes CRISPR assembly for Synechocystis PCC6803 and named it pCRPB1010. The technique presented here using deadCas9 is easier to implement for gene silencing in Synechocystis PCC6803 than other existing techniques as it circumvents the genome integration and segregation steps thereby significantly shortens the construction of the mutant strains. We executed CRISPR interference against well characterized photosynthetic genes to get a clear phenotype to validate the potential of pCRPB1010 and presented the work as a "proof of concept". Targeting the non-template strand of psbO gene resulted in decreased amount of PsbO and 50% decrease in oxygen evolution rate. Targeting the template strand of psbA2 and psbA3 genes encoding the D1 subunit of photosystem II (PSII) using a single spacer against the common sequence span of the two genes, resulted in full inhibition of both genes, complete abolition of D1 protein synthesis, complete loss of oxygen evolution as well as photoautotrophic growth arrest. This is the first report of a single plasmid based, completely lesion free and episomal expression and execution of CRISPR interference in Synechocystis PCC6803.
我们开发了一种简单的方法,通过修改现有的 pCRISPathBrick 质粒来应用 CRISPR 干扰,该质粒包含用于 Synechocystis PCC6803 的天然 S. pyogenes CRISPR 组装,我们将其命名为 pCRPB1010。与其他现有技术相比,这里提出的使用 deadCas9 的技术更易于在 Synechocystis PCC6803 中进行基因沉默,因为它绕过了基因组整合和分离步骤,从而大大缩短了突变株的构建时间。我们针对光合作用基因进行了 CRISPR 干扰,以获得明确的表型来验证 pCRPB1010 的潜力,并将这项工作作为“概念验证”呈现。靶向 psbO 基因的非模板链导致 PsbO 含量减少,氧释放率降低 50%。靶向编码光系统 II (PSII) D1 亚基的 psbA2 和 psbA3 基因的模板链,使用针对两个基因共同序列跨度的单个间隔子,导致两个基因完全抑制,D1 蛋白合成完全被抑制,氧释放以及光自养生长完全停止。这是首例在 Synechocystis PCC6803 中,基于单个质粒、完全无损伤和附加体表达和执行 CRISPR 干扰的报道。